Brief: Fulcrum Therapeutics Announces Pricing Of Upsized $175.0 Million Public Offering Of Common Stock And Pre-Funded Warrants
10/12/2025 12:49
Dec 10 (Reuters) - Fulcrum Therapeutics Inc FULC.O: FULCRUM THERAPEUTICS ANNOUNCES PRICING OF UPSIZED $175.0 MILLION PUBLIC OFFERING OF COMMON STOCK AND PRE-FUNDED WARRANTS FULCRUM THERAPEUTICS INC - PRICES PUBLIC OFFERING OF 11.85 MILLION SHARES AT $13.50 FULCRUM THERAPEUTICS INC - UNDERWRITERS GRANTED OPTION FOR 1.94 MILLION ADDITIONAL SHARES Source text: ID:nGNX8XtPcN Further company coverage: FULC.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Fulcrum Therapeutics
See all newsFulcrum Therapeutics, Inc. expected to post a loss of 14 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE - Nvidia, Gold miners, Nike
U.S. STOCKS ON THE MOVE - Sunrun, JetBlue Airways, Dell Technologies
U.S. STOCKS ON THE MOVE - KBR, Vista Energy, Fulcrum Therapeutics
Fulcrum to merge with Slate in all-stock deal after drug setback